Indication
B7-H3 Positive Relapsed/Advanced Malignant Solid Tumor
1 clinical trial
1 product
Clinical trial
Phase I Clinical Study of UTAA06 Injection in Treatment of Patients With Advanced Malignant Solid TumorsStatus: Recruiting, Estimated PCD: 2024-12-01
Product
UTAA06